PDGF and Src tyrosine kinases in pulmonary arterial smooth muscle cells: Effects of dasatinib and nilotinib on pulmonary vascular remodeling
S. S. Pullamsetti, E. Burghaüsen, S. Dabral, E. Butrous, A. Tretyn, R. Savai, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, S. Rosenkranz, R. T. Schermuly (Bad Nauheim, Giessen, Cologne, Germany; Kent, United Kingdom)
Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. S. Pullamsetti, E. Burghaüsen, S. Dabral, E. Butrous, A. Tretyn, R. Savai, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, S. Rosenkranz, R. T. Schermuly (Bad Nauheim, Giessen, Cologne, Germany; Kent, United Kingdom). PDGF and Src tyrosine kinases in pulmonary arterial smooth muscle cells: Effects of dasatinib and nilotinib on pulmonary vascular remodeling. Eur Respir J 2011; 38: Suppl. 55, 410
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: